SIZE XSSIZE SMSIZE MDSIZE LG

Processes and Deadlines

HOPA defines an encore submission as one that has been previously presented elsewhere, prior to it being presented at the HOPA annual meeting. Please note: Encore Presentations will NOT be accepted as Late Breaking research or as a Platform Presentation at HOPA’s Annual Conference.

*You will submit your Encore Research Abstract with the Completed Research submission form and deadlines.

Selected abstracts will be presented as ePosters at the Annual Conference. Type the abstract title in "title case," capitalizing the first letter of each word only. Submissions must have a title to be considered for the conference program.

There will be two categories of abstracts including:

  • Clinical/Translational Research – Clinical/Translational research projects are designed to investigate the safety and/or effectiveness of a medication, treatment strategy, or medication-containing device in humans. This may include but is not limited to laboratory-based studies, evaluation of pharmacist clinical interventions, prospective trials, and/or retrospective chart review.
  • Practice Management Research – Practice Management Research projects are designed to improve medication safety, establish best practices, and/or explore the role of the hematology/oncology pharmacist in patient care through the enhancement of pharmacy resources. This may include but is not limited to formulary management and order set/protocol development, optimization of resource utilization (e.g. medication procurement and distribution, cost savings or cost avoidance, outpatient infusion chair time reduction), quality improvement initiatives and expansion of service lines (e.g. collaborative practice agreements, billing for pharmacy provided services, implementation of patient education programs).

Topics for Clinical/Translational Research will include:

  • Hematology
  • Bone Marrow Transplantation
  • Solid Tumor
  • Supportive Care
  • Other

Topics for Practice Management Research will include:

  • Distribution of Services
  • Information Technology
  • Medication Safety
  • Management
  • Pharmacist Roles
  • Quality Improvement

All information entered on the abstract form will appear in print exactly as it is typed. It is recommended that the abstract is typed offline in a word processing document. After spelling and grammatical errors are edited, and the word count is verified, copy and paste the text into the online form.
Notification of acceptance and declination will be emailed to the address provided within six weeks of the submission deadline.

Encore Abstract Submissions are due October 19, 2018 at 5pm CST.

Abstract Structure

Obtain the Encore Research Abstract Template here.

Review Process

Encore research abstracts undergo an anonymous review by volunteer HOPA members serving on the Annual Conference Abstract Review Sub Committee. The Sub Committee is comprised of content experts in the same field of the submitted research whenever feasible. The Sub Committee makes final selections based on the results of the initial review. Abstracts that do not fulfill all requirements or are submitted after the posted deadline will not be reviewed. A disclosure of financial interest is required in order for a completed abstract to be peer reviewed.

Submit Encore Research Abstracts here.

For more information regarding criteria and frequently asked questions, please visit our Research Abstract FAQ page.

xs
sm
md
lg